---
title: "Pharm Stock KZ: Pharm Stock KZ runs a B2B platform for pharmacies to source medicines, view prices, and place wholesale orders."
url: https://emrr.uz/pharmstock
language: en
updated: 2026-11-18T13:44:24Z
source: emrr (https://emrr.uz)
---

# Pharm Stock KZ

Pharm Stock KZ runs a B2B platform for pharmacies to source medicines, view prices, and place wholesale orders.

[pharmstock.kz](https://www.pharmstock.kz)

- **Industry**: Other
- **Founded**: 2015
- **Team size**: 11-50 people
- **Based in**: Almaty, Kazakhstan

## Verified revenue: not connected yet

Is Pharm Stock KZ yours? Claim this page and connect Stripe, the App Store or Google Play: your MRR and growth show here, read straight from the source.

[Claim it if it’s yours](https://panel.emrr.uz/reserve/pharmstock)

## About

Pharm Stock KZ operates an online B2B platform for sourcing medicines and medical goods. The service aggregates offers from pharmaceutical suppliers, shows current stock and pricing, and enables registered buyers to place and manage wholesale orders. Features include catalog search by INN, brand or category, product details and documentation, order history, and status notifications. The platform supports integrations for bulk ordering and provides support channels for account verification and procurement queries. Logistics coordination and delivery scheduling are coordinated with suppliers, with attention to handling requirements for sensitive products. The company also shares regulatory updates relevant to pharmacy procurement. Primary users include pharmacies, clinics, and other professional buyers.

## Team

- **Klara Sarsembayeva**, Director

## Links

- [LinkedIn](https://www.linkedin.com/company/%D1%82%D0%BE%D0%BE-%D1%84%D0%B0%D1%80%D0%BC-%D1%81%D1%82%D0%BE%D0%BA-kz)

Profile data from Stanbase.

Updated 18 November 2026

[This page in Markdown](https://emrr.uz/pharmstock.md)

[Get your verified page](https://emrr.uz/): Connect Stripe, the App Store or Google Play in two minutes and get a page like this one. emrr reads every figure itself, so investors don’t have to take your word for it. Free while MRR is under $1,000.
